Janux Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JANX research report →
About the company
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors.
- CEO
- David Alan Campbell
- IPO
- 2021
- Employees
- 91
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $947.70M
- P/E
- -8.45
- P/S
- 43.85
- P/B
- 1.03
- EV/EBITDA
- -8.16
- Div Yield
- 0.00%
- Gross Margin
- 54.15%
- Op Margin
- -726.34%
- Net Margin
- -529.67%
- ROE
- -11.85%
- ROIC
- -16.15%
- Revenue
- $10.00M · -5.55%
- Net Income
- $-113,625,000 · -64.69%
- EPS
- $-1.83 · -42.97%
- Op Income
- $-157,667,000
- FCF YoY
- -88.53%
- 52W High
- $35.34
- 52W Low
- $12.12
- 50D MA
- $14.35
- 200D MA
- $17.64
- Beta
- 2.51
- Avg Volume
- 1.11M
Get TickerSpark's AI analysis on JANX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 15,500 |
| Jun 11, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 5,500 |
| Jun 11, 26 | Simson Jake | other | 15,500 |
| Jun 11, 26 | Simson Jake | other | 5,500 |
| Jun 11, 26 | Kung Winston | other | 15,500 |
| Jun 11, 26 | Kung Winston | other | 5,500 |
| Jun 11, 26 | Hernday Natasha | other | 15,500 |
| Jun 11, 26 | Hernday Natasha | other | 5,500 |
| Jun 11, 26 | DOBMEIER ERIC | other | 15,500 |
| Jun 11, 26 | DOBMEIER ERIC | other | 5,500 |
Our JANX coverage
Recent articles, reports, and earnings notes.
No research on JANX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate JANX report →Similar companies
Peers in the same neighborhood.